Your browser doesn't support javascript.
loading
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Zhou, Zhao-Hua; Cortese, Margaret M; Fang, Jia-Long; Wood, Robert; Hummell, Donna S; Risma, Kimberly A; Norton, Allison E; KuKuruga, Mark; Kirshner, Susan; Rabin, Ronald L; Agarabi, Cyrus; Staat, Mary A; Halasa, Natasha; Ware, Russell E; Stahl, Anna; McMahon, Maureen; Browning, Peter; Maniatis, Panagiotis; Bolcen, Shanna; Edwards, Kathryn M; Su, John R; Dharmarajan, Sai; Forshee, Richard; Broder, Karen R; Anderson, Steven; Kozlowski, Steven.
Affiliation
  • Zhou ZH; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Cortese MM; Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Fang JL; National Center for Toxicological Research, FDA, Jefferson, AR, USA.
  • Wood R; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hummell DS; Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Risma KA; Division of Allergy Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Norton AE; Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • KuKuruga M; Center for Biologics Evaluation and Research, Food and Drug Administration, USA.
  • Kirshner S; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Rabin RL; Center for Biologics Evaluation and Research, Food and Drug Administration, USA.
  • Agarabi C; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Staat MA; Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Halasa N; Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Ware RE; Division of Hematology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Stahl A; Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • McMahon M; Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Browning P; Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Maniatis P; Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Bolcen S; Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Edwards KM; Division of Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Su JR; Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Dharmarajan S; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, USA.
  • Broder KR; Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Anderson S; Center for Biologics Evaluation and Research, Food and Drug Administration, USA.
  • Kozlowski S; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: steven.kozlowski@fda.hhs.gov.
Vaccine ; 41(28): 4183-4189, 2023 06 23.
Article in En | MEDLINE | ID: mdl-37244808
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Anaphylaxis Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Vaccine Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Anaphylaxis Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Vaccine Year: 2023 Type: Article Affiliation country: United States